secwatch.observer — SEC 8-K summary
======================================

Issuer:     Semnur Pharmaceuticals, Inc. (SMNR)
CIK:        0001913577
Form:       8-K
Filed at:   2025-01-08T23:59:59+00:00
Accession:  0001213900-25-002085
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Denali Capital extends business combination deadline to Feb 11, 2025; deposits $15k via Scilex note
--------------------------------------------------------------------------------

- Deposited $15,063.74 into trust account to extend deadline from Jan 11 to Feb 11, 2025.
- Extension funded via convertible promissory note from Scilex Holding Company (SCLX) with principal up to $180,000.
- Note bears no interest, repayable upon business combination or liquidation; convertible at $10.00/share.
- Remaining $89,672.56 available under note to fund potential future one-month extensions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1913577/000121390025002085/0001213900-25-002085-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1913577/000121390025002085/ea0227100-8k425_denalicap.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-002085

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer